Renalytix (RENX) News Today GBX 8.01 -0.12 (-1.48%) As of 12:06 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Earnings call transcript: Renalytix AI Q4 2024 misses EPS, revenue beatsMarch 20, 2025 | uk.investing.comRenalytix Plc (RTNXF)January 7, 2025 | finance.yahoo.comRenalytix Successfully Passes All Resolutions at AGMDecember 20, 2024 | markets.businessinsider.comRenalytix Advances Strategic Goals with Funding and Market ExpansionDecember 19, 2024 | markets.businessinsider.comRenalytix Plc (LON:RENX) Insider Purchases £2,250 in StockDecember 12, 2024 | insidertrades.comRenalytix Leadership Engages in Notable Share TransactionsDecember 12, 2024 | markets.businessinsider.comRenalytix Plc (LON:RENX) Insider Purchases £4,264 in StockDecember 7, 2024 | insidertrades.comRenalytix Appoints Robert Naylor to Boost Strategic GrowthDecember 3, 2024 | markets.businessinsider.comRenalytix Strengthens Leadership with New DirectorDecember 3, 2024 | markets.businessinsider.comRenalytix Releases Annual Report and AGM DetailsNovember 26, 2024 | markets.businessinsider.comRenalytix AI Targets Profitability with Kidney Test SalesNovember 21, 2024 | markets.businessinsider.comRenalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025November 21, 2024 | finanznachrichten.deRenalytix Reports Reduced Losses and Strong Financial OutlookNovember 21, 2024 | markets.businessinsider.comRenalytix PLC Sees Major Voting Rights ShiftNovember 7, 2024 | markets.businessinsider.comRenalytix Sees Major Shift in Voting RightsNovember 7, 2024 | markets.businessinsider.comRenalytix Appoints Julian Baines as Executive ChairmanNovember 5, 2024 | markets.businessinsider.comChristopher H. B. Mills Sells 83,696 Shares of Renalytix Plc (LON:RENX) StockOctober 13, 2024 | insidertrades.comCommencement of trading on OTCQB in the United StatesOctober 8, 2024 | finance.yahoo.comRenalytix (NASDAQ:RNLX) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comRenalytix AI plc (2O9.MU)August 29, 2024 | uk.finance.yahoo.comLatest News for Renalytix Stock (NASDAQ:RNLX)May 28, 2024 | benzinga.comIs Renalytix the best penny stock to buy today?March 9, 2024 | uk.finance.yahoo.comRNLX Mar 2024 2.500 callFebruary 17, 2024 | finance.yahoo.comRenalytix plc: Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024February 15, 2024 | finanznachrichten.deRenalytix AI plc (RENX)February 15, 2024 | uk.investing.comRenalytix Plc (RNLX) stock price, news, quote & history – Yahoo FinanceFebruary 14, 2024 | nz.finance.yahoo.comRenalytix PLC RENXFebruary 13, 2024 | morningstar.comAfter the Renalytix share price jumps 500% in 3 days, is it time to buy?February 13, 2024 | uk.finance.yahoo.comRenalytix plc: New published data demonstrates KidneyIntelX has broad implications for winning war on chronic kidney diseaseJanuary 10, 2024 | finanznachrichten.deRenalytix Stock (NASDAQ:RNLX) Earnings Dates and Earning CallsNovember 15, 2023 | benzinga.comRenalytix Reports Full Year Fiscal 2023 ResultsSeptember 28, 2023 | markets.businessinsider.comRenalytix Appoints Senior Executive Howard Doran as Chief Business OfficerSeptember 7, 2023 | finance.yahoo.comRenalytix Appoints Financial Executive Catherine Coste to its Board of DirectorsJuly 3, 2023 | finance.yahoo.comFDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney DiseaseJune 29, 2023 | finance.yahoo.comKidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific ConferencesJune 15, 2023 | finance.yahoo.comIs the Renalytix share price a bargain or a falling knife?May 31, 2023 | uk.movies.yahoo.comNew Published Real-World Evidence Shows KidneyIntelX(TM) UtilityApril 20, 2023 | marketwatch.comNew Published Real-World Evidence Shows KidneyIntelX™ UtilityApril 19, 2023 | finance.yahoo.comData Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical MeetingApril 12, 2023 | finance.yahoo.comRenalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial ResultsMarch 30, 2023 | finance.yahoo.comRenalytix Shares Fall on Delay to FDA Marketing Authorization Decision on KidneyIntelXMarch 21, 2023 | marketwatch.comRenalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceFebruary 9, 2023 | finance.yahoo.comRenalytix announces a c.$20.3 million private placementFebruary 8, 2023 | finance.yahoo.comRenalytix Shares Rise on $10 Mln Grant Award to Advance Chronic Kidney Disease TreatmentJanuary 26, 2023 | marketwatch.comRenalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United StatesJanuary 26, 2023 | finance.yahoo.comRenalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systemsJanuary 9, 2023 | finance.yahoo.comPrimary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and OutcomesDecember 1, 2022 | finance.yahoo.comRenalytix AI, Inc.: Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023November 30, 2022 | finanznachrichten.deWhat’s going on with the Renalytix share price?November 30, 2022 | msn.comRenalytix plc: Renalytix Reports Full Year Fiscal 2022 ResultsOctober 31, 2022 | finanznachrichten.de Remove Ads Get Renalytix News Delivered to You Automatically Sign up to receive the latest news and ratings for RENX and its competitors with MarketBeat's FREE daily newsletter. Email Address RENX Media Mentions By Week RENX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RENX News Sentiment▼0.000.64▲Average Medical News Sentiment RENX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RENX Articles This Week▼00▲RENX Articles Average Week Remove Ads Get Renalytix News Delivered to You Automatically Sign up to receive the latest news and ratings for RENX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Kooth News Today Cambridge Cognition News Today Feedback News Today Induction Healthcare Group News Today IQ-AI News Today Craneware News Today Tristel News Today Avacta Group News Today Bioventix News Today EKF Diagnostics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:RENX) was last updated on 4/7/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renalytix Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Renalytix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.